clinical trial · NCT00216827
Efficacy and Safety of Calcipotriol Plus Betamethasone Gel in the Treatment of Scalp Psoriasis
LEO Pharma·phase3·completed·n = 1,485
Psoriasis of ScalpCalcipotriol plus betamethasone dipropionate (LEO80185 gel)
brief summary
The purpose of this study is to evaluate whether once daily treatment for up to 8 weeks of calcipotriol 50 mcg/g plus betamethasone 0.5 mg/g (as dipropionate) gel is safe and more effective than betamethasone 0.5 mg/g (as dipropionate) in the gel vehicle, calcipotriol 50 mcg/g in the gel vehicle or the gel vehicle used alone in patients with scalp psoriasis. The primary outcome is the proportion of patients with absence of disease or very mild disease after 8 weeks of treatment.
started
Nov 1, 2004
primary completion
—
completion
Sep 1, 2005
last updated
Feb 24, 2025
official title
Calcipotriol Plus Betamethasone Dipropionate Gel Compared to Betamethasone Dipropionate in the Gel Vehicle, Calcipotriol in the Gel Vehicle, and the Gel Vehicle Alone in Scalp Psoriasis
sourced from ClinicalTrials.gov · pharmadog mirrors structured fields, not the full protocol